TABLE 4.
The results of clinical evaluation and comparison.
| Feature | Overall | 2019/07-11 (without AI) | 2020/07-11 (with AI) | P-Value |
|
|
||||
| N = 171 | N = 78 | N = 93 | ||
| (A) Analysis of weaning rate | ||||
| Age, mean ± SD | 66.2 ± 15.7 | 65.7 ± 16.3 | 66.7 ± 15.2 | 0.695 |
| Gender | ||||
| Female, n (%) | 58 (33.9) | 29 (37.2) | 29 (31.2) | 0.507 |
| Male, n (%) | 113 (66.1) | 49 (62.8) | 64 (68.8) | |
| APACHE II score, mean ± SD | 20.8 ± 8.5 | 20.3 ± 8.7 | 21.7 ± .5 | 0.262 |
| TISS, mean ± SD | 30.6 ± 6.5 | 30.1 ± 6.8 | 31.0 ± 6.4 | 0.243 |
| COMA scale, mean ± SD | 8.7 ± 3.5 | 9.1 ± 3.6 | 8.3 ± 3.4 | 0.068 |
| Extubation | ||||
| Successful, n (%) | 167 (97.7) | 76 (97.4) | 91 (97.8) | 1.000 |
| Failure, n (%) | 4 (2.3) | 2 (2.6) | 2 (2.2) | |
|
| ||||
| Feature | Overall | 2019/07-11 (without AI) | 2020/07-11 (with AI) | P-Value |
|
|
||||
| N = 167 | N = 76 | N = 91 | ||
|
| ||||
| (B) Analysis of successful weaning use-time | ||||
| Age, mean ± SD | 66.0 ± 15.8 | 65.7 ± 16.4 | 66.4 ± 15.1 | 0.814 |
| Gender | ||||
| Female, n (%) | 56 (33.5) | 29 (38.2) | 27 (29.7) | 0.321 |
| Male, n (%) | 111 (66.5) | 47 (61.8) | 64 (70.3) | |
| APACHE II score, mean ± SD | 20.9 ± 8.5 | 20.4 ± 8.8 | 21.8 ± 8.5 | 0.278 |
| TISS, mean ± SD | 30.7 ± 6.5 | 30.3 ± 6.8 | 31.1 ± 6.4 | 0.318 |
| COMA scale, mean ± SD | 8.6 ± 3.5 | 9.0 ± 3.5 | 8.3 ± 3.5 | 0.099 |
| Intubation hours, mean ± SD | 170.9 ± 150.7 | 178.0 ± 147.7 | 156.6 ± 150.4 | 0.300 |
| ICU Days, mean ± SD | 9.3 ± 7.5 | 9.3 ± 8.0 | 8.8 ± 6.9 | 0.631 |